Stockholm - November 8th 2016 - Building on the acquisition of HERMES Medical Solutions by Segulah V L.P. in April of 2016, Segulah continues to invest in HERMES and is going to expand the investments to drive growth and market access for HERMES Medical Solutions. The investments include both operations and development and ensure HERMES to further focus on providing the best solutions for Molecular Imaging and concentrate on the success of our customers and the clinical outcomes for patients.

“We continue to execute the strategy that was developed for the global growth of HERMES Medical Solutions”, says Sofia Bertling, CEO of HERMES. “The positive impact of the Segulah investments enables the targeting of long term sustainable value creation with our install base with existing partnerships and will help to build even more relations.”

If you want to learn more about how HERMES is going to improve customer support, develop innovations, and provide solutions for clinical excellence, visit us at our booth (Exhibit Hall A – 2969) at the RSNA 2016 in Chicago between November 27 and December 2.

HERMES MEDICAL SOLUTIONS
With more than 40 years of recognition for Clinical Excellence and innovation in Molecular Imaging, HERMES delivers Enterprise Class systems and software for integrating, visualizing, processing and archiving imaging data from different imaging modalities and devices within Molecular Imaging and Radiology. HERMES solutions are empowering physicians by enabling faster and more accurate diagnosis and treatment of patients, thereby improving quality and increasing efficiency for healthcare providers pursuing refined clinical pathways in Precision Medicine.